The results showed that treatment with CPC NPs combined with UTMD in MPTP-induced PD mice notably improved behavioral disturbance, dopamine depletion, and TH expression, as well as reduced α-synuclein (AS) expression, showing that the delivery of CUR with this treatment was efficient, as well as its therapeutic effects against PD. This evidence concerns the gene TH and Parkinson disease.